Ellevest Inc’s Meridian Bioscience Inc VIVO Stock Holding History

Ellevest Inc’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15	Closed	-$498	–	2124
2022 Q4	$498	Sell	15 -1	-6%	-$32	﹤0.01%	1620
2022 Q3	$1K	Buy	+16	New	+$518	﹤0.01%	1560
2020 Q4	–	Sell	-4	Closed	–	–	1411
2020 Q3	$0	Buy	+4	New	+$78	﹤0.01%	1370

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ellevest Inc's VIVO Position: Q1 2023 in Review

Ellevest Inc sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 15 shares — an estimated $498 sold.

Ellevest Inc first reported a position in VIVO in Q3 2020 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Ellevest Inc reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Ellevest Inc sold 15 Meridian Bioscience Inc shares in Q1 2023, an estimated $498.
Ellevest Inc first reported a position in Meridian Bioscience Inc in Q3 2020 and held it in 3 quarters.
Ellevest Inc's Meridian Bioscience Inc position peaked at $1K in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.